24 Jul A Harris Win Could Boost FTC, NIH Drug Pricing Roles Given Presumptive Candidate’s Prior Anticompetitive Crackdown, March-In Support
Gabrielle Wanneh and Maaisha Osman
Inside Health Policy, 7/24/2024...
News
21 Jul NIH Intramural Licensing Guidelines Hit the Wrong Note at the Wrong Time
Joseph Allen
IPWatchdog, 7/21/2024
...
19 Jul Don’t Justify March-in With Myth That ‘Government Funds Drugs’
Fred Reinhart & Mark Rohrbaugh
RealClearHealth, 7/19/2024 ...
01 Jul Cassidy Targets March-In Rights Again After Supreme Court’s Ruling On Chevron Deference
Jalen Brown and Gabrielle Wanneh
Inside Health Policy, 7/1/2024...
20 Jun This law made ORNL a commercial powerhouse. A federal agency could jeopardize it
Daniel Dassow
Knoxville News Sentinel, 6/20/2024...
13 Jun Federal policy changes would hamstring Pennsylvania’s economy and hurt patients
Steven Infanti
The Patriot-News, 6/12/2024...
04 Jun A debate over a federal bill that has played a key role in medical innovation
Joseph P. Allen
The Washington Post, 6/4/2024
...
16 May Industry Tells USPTO Biden March-In Proposal Undermines Inquiry to Improve IP Commercialization
Eileen McDermott
IPWatchdog, 5/16/2024...
13 May Making Licensing Harder Doesn’t Boost U.S. Manufacturing
Joseph Allen
IPWatchdog, 5/13/2024...
12 May Biden administration plan would gut Indiana’s innovation economy
Brooke Beier
Times of Northwest Indiana, 5/12/2024...